1. Home
  2. RGNX vs BWB Comparison

RGNX vs BWB Comparison

Compare RGNX & BWB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGNX
  • BWB
  • Stock Information
  • Founded
  • RGNX 2008
  • BWB 2005
  • Country
  • RGNX United States
  • BWB United States
  • Employees
  • RGNX N/A
  • BWB N/A
  • Industry
  • RGNX Biotechnology: Biological Products (No Diagnostic Substances)
  • BWB Major Banks
  • Sector
  • RGNX Health Care
  • BWB Finance
  • Exchange
  • RGNX Nasdaq
  • BWB Nasdaq
  • Market Cap
  • RGNX 451.1M
  • BWB 442.3M
  • IPO Year
  • RGNX 2015
  • BWB 2018
  • Fundamental
  • Price
  • RGNX $12.50
  • BWB $17.03
  • Analyst Decision
  • RGNX Strong Buy
  • BWB Strong Buy
  • Analyst Count
  • RGNX 8
  • BWB 2
  • Target Price
  • RGNX $28.50
  • BWB $20.00
  • AVG Volume (30 Days)
  • RGNX 525.7K
  • BWB 151.4K
  • Earning Date
  • RGNX 11-05-2025
  • BWB 10-21-2025
  • Dividend Yield
  • RGNX N/A
  • BWB N/A
  • EPS Growth
  • RGNX N/A
  • BWB 12.01
  • EPS
  • RGNX N/A
  • BWB 1.21
  • Revenue
  • RGNX $155,782,000.00
  • BWB $119,312,000.00
  • Revenue This Year
  • RGNX $203.79
  • BWB $35.51
  • Revenue Next Year
  • RGNX $0.72
  • BWB $11.83
  • P/E Ratio
  • RGNX N/A
  • BWB $14.56
  • Revenue Growth
  • RGNX 74.95
  • BWB 12.23
  • 52 Week Low
  • RGNX $5.04
  • BWB $11.93
  • 52 Week High
  • RGNX $12.28
  • BWB $18.01
  • Technical
  • Relative Strength Index (RSI)
  • RGNX 76.74
  • BWB 51.33
  • Support Level
  • RGNX $10.24
  • BWB $16.53
  • Resistance Level
  • RGNX $11.00
  • BWB $17.86
  • Average True Range (ATR)
  • RGNX 0.63
  • BWB 0.58
  • MACD
  • RGNX 0.28
  • BWB -0.03
  • Stochastic Oscillator
  • RGNX 93.57
  • BWB 36.03

About RGNX REGENXBIO Inc.

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.

About BWB Bridgewater Bancshares Inc.

Bridgewater Bancshares Inc is a financial holding company. Through its subsidiary, it offers various personal and commercial banking products and services such as savings accounts, certificates of deposits, money transfer services, digital wallets, credit and debit cards, safe deposit lockers, different types of loans and advances, commercial deposit accounts, treasury management, and others. The company principally focuses on catering to commercial clients, offering them a suite of loan and deposit products. Geographically, it mainly operates in the Twin Cities Metropolitan Statistical Area in the United States.

Share on Social Networks: